10-Q: Forian Reports Strong Revenue Growth, Reduced Net Loss in Q3 2025
Quarterly Report
Forian Inc. announced significant revenue growth and a narrower net loss for the third quarter and nine months ended September 30, 2025, driven by the Kyber acquisition and organic growth.
Summary
- Revenue for the three months ended September 30, 2025, increased by 65.6% to $7.76 million, up from $4.69 million in the same period of 2024.
- Year-to-date revenue for the nine months ended September 30, 2025, rose by 55.5% to $22.29 million, compared to $14.34 million in the prior year.
- Net loss for the third quarter of 2025 improved to $(0.15) million from $(0.20) million in Q3 2024.
- Year-to-date net loss significantly improved to $(1.05) million from $(3.97) million in the prior year.
- Adjusted EBITDA for Q3 2025 increased by 153.1% to $0.47 million, and year-to-date Adjusted EBITDA grew by 174.3% to $1.01 million.
- The company fully repaid its $6.84 million convertible notes on September 1, 2025.
- Net cash used in operating activities decreased significantly to $(0.34) million for the nine months ended September 30, 2025, from $(1.47) million in the prior year.
- Cash and marketable securities totaled $28.23 million as of September 30, 2025.
- The Kyber acquisition, effective October 31, 2024, contributed $1.99 million in revenue for Q3 2025 and $5.55 million year-to-date.
Sentiment
Score: 7
Explanation: The company demonstrated strong revenue growth and significantly improved its net loss and Adjusted EBITDA, while also eliminating its convertible debt. However, the decrease in gross profit margin and the ongoing challenges with key information vendors, coupled with an un-remediated internal control weakness, temper the overall positive sentiment.
Positives
- Significant revenue growth: 65.6% for Q3 2025 and 55.5% for the nine months ended September 30, 2025, driven by the Kyber acquisition and organic growth.
- Improved operating loss and net loss for both the quarter and nine-month periods, indicating enhanced operational efficiency.
- Strong growth in Adjusted EBITDA, increasing by 153.1% for Q3 and 174.3% year-to-date, reflecting better underlying business performance.
- Successful repayment of all outstanding convertible notes totaling $6.84 million, eliminating a significant debt obligation and reducing future interest expense.
- Improved cash flow from operating activities, reducing cash used by $1.13 million year-over-year, demonstrating better cash management.
- Remediation of a material weakness in internal controls related to payables transactions, enhancing financial reporting reliability.
- Resolution of two significant legacy legal proceedings (Audet v. Green Tree International and Grant Whitus et al. v. Forian Inc.), removing potential liabilities and distractions.
Negatives
- Gross profit as a percentage of revenues decreased to 52% in Q3 2025 from 70% in Q3 2024, and to 55% year-to-date from 66%, primarily due to higher information licensing and processing expenses from the Kyber acquisition.
- Interest and investment income decreased significantly due to a lower marketable securities balance, as funds were utilized to retire convertible notes.
- Accumulated deficit increased to $(50.97) million as of September 30, 2025, from $(49.92) million at December 31, 2024, reflecting ongoing losses.
- A material weakness in internal controls over the application of ASC 606 to contracts with variable revenues remains, though improvements have been implemented, indicating a continued risk to financial reporting accuracy.
Risks
- Reliance on third-party information vendors: One key vendor will no longer include certain data by December 31, 2024, and plans to exit the data licensing business by the end of 2026, requiring the company to secure alternate data sources which may not be comparable or on equivalent terms.
- Uncertainty in obtaining alternate data sources for information products, which could materially impact the business operations and revenue generation.
- Contingencies related to legal claims and proceedings, which are inherently unpredictable and can divert management attention and incur costs, despite recent settlements.
- Estimates and assumptions used in financial reporting, particularly for revenues, stock-based compensation, income taxes, and business combinations, could prove incorrect and materially impact financial statements.
- The material weakness in internal controls over the application of ASC 606 to contracts with customers is not yet fully remediated, posing a risk to financial reporting accuracy and compliance.
Future Outlook
The company expects to continue funding operations and potential future acquisitions through cash flow from operating activities, available cash and marketable securities, debt financing, and/or additional equity issuances. It plans to continue investing in marketing and sales by expanding staff, building brand awareness, attracting new clients, and sponsoring additional marketing events. The company is evaluating its rights and future obligations regarding a key information vendor's announced exit from the data licensing business by the end of 2026 and plans to license data from additional vendors.
Management Comments
- The increase [in revenue] is primarily due to the impact of the acquisition of Kyber and organic growth in sales of the Company's information products.
- The decrease [in general and administrative expenses] is primarily due to lower stock compensation expense.
- The decrease [in interest and investment income] is primarily due to a lower marketable securities balance resulting from the use of funds to retire convertible notes.
- The decrease [in interest expense] is due to the impact of the redemption of the Company's convertible notes.
- The increase [in Adjusted EBITDA] is primarily due to higher revenues, partially offset by the increased cost of revenues and other operating expenses discussed above.
- The Company expects to continue to fund its operations and potential future acquisitions through a combination of cash flow generated from operating activities, available cash and marketable securities, debt financing and/or additional equity issuances.
Industry Context
Forian operates in the healthcare, life sciences, and financial services industries, providing data management and analytics solutions. The significant revenue growth, partly driven by the Kyber acquisition, suggests a strong demand for specialized data and analytics in these sectors. However, challenges with information vendors exiting the data licensing business highlight the dynamic nature of data supply chains and the need for robust vendor management and diversification strategies in the industry.
Comparison to Industry Standards
- The company's revenue growth rates (65.6% for Q3 and 55.5% YTD) are exceptionally strong, potentially outperforming many industry peers, especially given the contribution from the Kyber acquisition.
- The decrease in gross profit percentage (from 70% to 52% in Q3) suggests that the acquired Kyber business or new organic growth initiatives may have higher associated costs of revenue compared to the company's historical operations, which could be a point of concern if not managed effectively relative to industry benchmarks for data and analytics providers.
- The successful repayment of convertible notes and reduction in interest expense positions the company with a healthier balance sheet, potentially better than highly leveraged competitors in growth-oriented tech sectors.
- The ongoing material weakness in ASC 606 application, while being addressed, indicates a need for continued improvement in financial reporting controls, which could lag behind best practices of more mature, larger industry players.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Amendment | Stockholders approved an amendment to the 2020 Equity Incentive Plan on June 11, 2025, increasing the number of shares available for issuance by 4,000,000 to a total of 10,400,000 shares. | 2025-06-11 | Increases the pool of shares available for stock-based compensation, potentially impacting dilution but also providing flexibility for employee incentives and future capital raises. |
| Internal Control Remediation | Remediation of a material weakness in the design of controls over payables transactions, with additional controls implemented and operating effectively as of September 30, 2025. | 2025-09-30 | Enhances financial reporting reliability and reduces the risk of fraudulent or fictitious payments. |
| Internal Control Improvement | Implementation of improvements in the design of controls over the application of ASC 606 to contracts with customers, addressing a previously identified material weakness. | 2025-09-30 | Aims to improve accuracy and compliance in revenue recognition, though full remediation is still pending. |
Legal Proceedings
- Audet v. Green Tree International, et al.: A lawsuit filed on February 14, 2020, claiming 10% ownership of Green Tree International (an indirect subsidiary). Settled and dismissed with prejudice on March 27, 2024.
- Grant Whitus et al. v. Forian Inc., Zachary Venegas and Scott Ogur: A lawsuit filed on July 30, 2021, by former Helix employees claiming breach of contract and other damages related to promised equity or compensation. Settled and dismissed with prejudice on June 7, 2024.
Related Party Transactions
- Adam Dublin, Chief Strategy Officer, received $0 in runoff commissions from a current vendor for the three and nine months ended September 30, 2025 (compared to $24,375 and $60,025 for the same periods in 2024).
- A customer agreement was entered into on September 4, 2024, with an entity controlled by one of the directors, providing for products and services with aggregate minimum billings of $1,200,000 and noncash consideration of $133,914. Revenues from this agreement were $59,224 for Q3 2025 and $277,079 for YTD September 2025.
Stakeholder Impact
- Shareholders: Positive impact from strong revenue growth, improved profitability metrics (net loss, Adjusted EBITDA), and debt reduction. Potential for future dilution from increased shares available for issuance and potential equity raises. Share repurchases indicate management's confidence and return capital to shareholders.
- Employees: Positive impact from stock-based compensation, with new options and restricted stock units granted.
- Customers: Continued provision of data management and analytics solutions. Potential for disruption if alternate data sources are not secured effectively following vendor changes.
- Creditors: Positive impact from the full repayment of convertible notes, significantly reducing the company's debt obligations.
- Suppliers/Vendors: Impacted by changes in licensing agreements, with one vendor exiting the data licensing business and another agreement terminated.
Next Steps
- License data from additional vendors to mitigate the impact of a key information vendor exiting the data licensing business.
- Continue to implement and test improvements in internal controls over the application of ASC 606 to contracts with customers to fully remediate the identified material weakness.
- Continue investing in marketing and sales by expanding staff, building brand awareness, attracting new clients, and sponsoring additional marketing events.
- Evaluate rights and future obligations under the contract with the vendor exiting the data licensing business.
- File a method of accounting change for capitalized domestic R&E expenditures as of January 1, 2025, with a 481(a) adjustment in the 2025 taxable year, following the OBBBA enactment.
Key Dates
| Date | Description |
|---|---|
| 2020-02-14 | John Audet filed a complaint against Green Tree International (GTI), an indirect subsidiary, claiming 10% ownership of GTI. |
| 2020-10-15 | Forian Inc. incorporated in Delaware. |
| 2021-07-30 | Four former Helix employees filed a lawsuit against the Company and Helix's former managers. |
| 2021-09-01 | Company issued $24,000,000 in 3.5% Convertible Promissory Notes due September 1, 2025. |
| 2022-06-15 | Stockholders approved an amendment to the 2020 Equity Incentive Plan, increasing shares available for issuance by 2,400,000. |
| 2023-02-10 | Company sold Bio-Tech Medical Software, Inc. (BioTrack) for $30,000,000. |
| 2023-07-21 | Company sold a minority equity interest in a customer for $5,805,858 cash and contingent earnout payments. |
| 2023-11-22 | Company entered into a Settlement Agreement and Release with the fifth plaintiff in the Grant Whitus et al. lawsuit. |
| 2023-12-12 | Fifth plaintiff in Grant Whitus et al. lawsuit filed a stipulation dismissing her claims. |
| 2023-12-15 | Effective date for ASU 2023-09 for public business entities for annual periods beginning after this date. |
| 2024-02-28 | Company redeemed $1,000,000 in principal and $87,356 of accrued interest on convertible notes for $950,000, resulting in a gain of $137,356. |
| 2024-03-08 | Parties in Audet v. Green Tree International et al. entered into a Settlement Agreement and General Release. |
| 2024-03-18 | Parties in Audet v. Green Tree International et al. filed a Joint Stipulation to Dismiss with Prejudice. |
| 2024-03-27 | Court entered a Final Order of Dismissal with Prejudice for Audet v. Green Tree International et al. |
| 2024-04-11 | Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC. Also, the death of a director who held $6,000,000 of convertible notes. |
| 2024-05-31 | Remaining parties in Grant Whitus et al. v. Forian Inc. entered into a Settlement Agreement and Release. |
| 2024-06-07 | Plaintiffs in Grant Whitus et al. v. Forian Inc. filed a Stipulation of Dismissal, and the Court entered a Minute Order dismissing the case with prejudice. |
| 2024-07-01 | Company renewed its lease agreement for office space in Hingham, Massachusetts, for an initial term of two years. |
| 2024-07-29 | Company purchased and retired 30,000 shares of common stock for $74,400 in a private transaction. |
| 2024-07-31 | Company informed by an information vendor that certain data would no longer be included in licensed products effective December 31, 2024. |
| 2024-09-04 | Company entered into a customer agreement with an entity controlled by one of its directors. |
| 2024-09-23 | Company informed by an information vendor of the termination of their agreement effective September 25, 2024. |
| 2024-10-04 | Company purchased and retired 100,000 shares of common stock for $218,500 in a private transaction. |
| 2024-10-31 | Kyber Acquisition Date: Company acquired all outstanding equity interests of Kyber Data Science, LLC. |
| 2024-11-11 | Company redeemed $16,000,000 in principal and $1,794,110 of accrued interest on convertible notes for $17,648,406, resulting in a gain of $145,703. |
| 2024-12-15 | Effective date for ASU 2024-03 for annual periods beginning after this date. |
| 2025-02-01 | Information vendor announced intent to exit data licensing business by end of 2026. |
| 2025-06-11 | Company's stockholders approved an amendment to the 2020 Plan, increasing shares available for issuance by 4,000,000 to a total of 10,400,000 shares. |
| 2025-07-02 | Company entered into a Termination and Wind Down Agreement with a vendor, reducing fees by $175,000. |
| 2025-07-04 | The One Big Beautiful Bill Act (OBBBA) was enacted, introducing changes to U.S. federal tax system. |
| 2025-07-18 | Company purchased and retired 90,000 shares of common stock for $176,400 at $1.96 per share. |
| 2025-08-25 | Company purchased and retired 122,500 shares of common stock for $240,100 at $1.96 per share. |
| 2025-09-01 | Convertible Notes matured, and the Company repaid all outstanding principal and accrued interest for $6,840,000. |
| 2025-09-30 | End of the fiscal quarter covered by this report. |
| 2025-11-02 | Board approved the grant of 12,000 nonqualified stock options and 230,000 restricted stock units to certain employees. |
| 2025-11-13 | Number of common stock shares outstanding was 31,072,252. |
| 2025-12-15 | Effective date for ASU 2025-05 for annual reporting periods beginning after this date. |
| 2026-12-31 | Expected end of extended transition period for complying with new or revised financial accounting standards under the JOBS Act. |
| 2027-12-15 | Effective date for ASU 2024-03 for interim reporting periods beginning after this date. |
Recommendation
holdWhile Forian Inc. demonstrated impressive revenue growth and a significant reduction in net loss and operating expenses, driven largely by the Kyber acquisition and debt repayment, several factors warrant a 'hold' recommendation. The substantial decrease in gross profit margin, coupled with the strategic risk posed by key information vendors exiting the data licensing business, introduces uncertainty regarding future profitability and operational stability. Additionally, the ongoing material weakness in internal controls over revenue recognition, despite remediation efforts, suggests a need for continued vigilance. The company has improved its financial position by eliminating convertible debt, but the path to sustained profitability and effective mitigation of data supply risks needs to be closely monitored before a more bullish stance can be taken. Investors should observe how the company addresses these operational and control challenges.
Keywords
Forian Inc., FORA, SEC Filing, 10-Q, Quarterly Report, Financial Results, Revenue Growth, Net Loss, Adjusted EBITDA, Kyber Acquisition, Data Analytics, Healthcare, Life Sciences, Financial Services, Convertible Notes, Internal Controls, Stock Repurchase, Information Products, Risk Factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.